Jim Cramer reviews 10 stocks leading the Dow now
CNBC’s Jim Cramer on Thursday thought it worthwhile to review ten stocks that led the Dow Jones Industrial Average over the ...
This ETF briefly beat the S&P 500 in 2025. Why one analyst remains cautious.
Despite briefly outperforming the cap-weight S&P 500 in 2025, RSP has widely lagged its more popular counterpart in the current bull market, up only 42% compared with its counterpart's nearly 70% ...
Energy stocks weigh down S&P 500
U.S. equity indexes turned mostly lower in afternoon trade, with energy stocks weighing on the S&P 500. The Dow was off about 240 points, or 0.5%, near 44,636, off the session's low of 44,545.27, ...
Stock Market Today: Dow Slips; Investors Dig Into Results Deluge
Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.
Finnair January Passenger Numbers Rose 6.6% on Year
Finnair carried 878,000 passengers in January, up 6.6% from a year earlier and compared with 927,000 passengers in December. The Finnish flag carrier said Thursday that the total cargo weight it ...
Stock Market Today: Dow, S&P 500 Futures Waver; Bank of England Cuts Rates
Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.
Lilly says Mounjaro and Zepbound contributed to big revenue boost
Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.